Yen Liao

Yen Liao is cofounder and COO of Opus Medical Therapies. Prior to Opus, Yen was one of the first engineers at CardiAQ Valve Technologies (acquired by Edwards lifesciences) developing a first-generation TMVR device. Yen was also an early engineer at eValve (acquired by Abbott Vascular) developing the Mitraclip transseptal delivery system. He has a BSME from Tufts University and is an inventor on 15+ patents.